fremanezumab-vfrm
fremanezumab-vfrm is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including AJOVY. Available dosage form: injection.
Drug Details
- Generic Name
- fremanezumab-vfrm
- Brand Names
- AJOVY
- Application Number
- BLA761089
- Sponsor
- Teva Pharmaceuticals USA, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- FREMANEZUMAB
Indications and Usage
1 INDICATIONS AND USAGE AJOVY is indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. AJOVY is a calcitonin gene-related peptide antagonist indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. ( 1 )